Avg closing price
Price range

22 Ken Griffin Reata Pharmaceuticals Trades

Ken Griffin acquired 156 Thousand Reata Pharmaceuticals shares worth $14.4 Million. That's 0.02% of their equity portfolio (976th largest holding). The first Reata Pharmaceuticals trade was made in Q3 2017. Since then Ken Griffin bought shares 36 more times and sold shares on 21 occasions. The stake costed the investor $10.6 Million, netting the investor a gain of 36% so far.

Avg closing price
Price range
Sold 56.8% shares (-42.4 Thousand shares) Q1 2023
Avg closing price $58.68
Price range $30.85 - $93.17
Sold 53.9% shares (-87.2 Thousand shares) Q4 2022
Avg closing price $34.41
Price range $22.15 - $42.11
Sold 29.2% shares (-66.7 Thousand shares) Q3 2022
Avg closing price $27.71
Price range $19.32 - $36.49
Increased shares by 77.3% (+99.7 Thousand shares) Q2 2022
Avg closing price $29.83
Price range $20.71 - $36.50
Increased shares by 113.2% (+68.4 Thousand shares) Q1 2022
Avg closing price $29.67
Price range $24.12 - $39.60
Increased shares by 875.6% (+54.2 Thousand shares) Q4 2021
Avg closing price $77.38
Price range $25.61 - $110.96
New holding (+6.19 Thousand shares) Q3 2021
Avg closing price $117.22
Price range $100.00 - $143.02
Sold -21.2 Thousand shares Q2 2021
Avg closing price $112.92
Price range $78.27 - $151.29
Sold 37.3% shares (-12.6 Thousand shares) Q1 2021
Avg closing price $116.64
Price range $94.25 - $132.81
Sold 37.0% shares (-19.9 Thousand shares) Q3 2020
Avg closing price $124.95
Price range $93.53 - $163.34
Sold 29.2% shares (-22.1 Thousand shares) Q2 2020
Avg closing price $152.02
Price range $126.30 - $176.56
Increased shares by 123.5% (+42 Thousand shares) Q1 2020
Avg closing price $193.06
Price range $124.16 - $247.74
Increased shares by 154.0% (+20.6 Thousand shares) Q4 2019
Avg closing price $182.82
Price range $74.57 - $217.92
Increased shares by 69.9% (+5.5 Thousand shares) Q3 2019
Avg closing price $84.86
Price range $71.26 - $95.75
Sold 46.5% shares (-6.83 Thousand shares) Q2 2019
Avg closing price $86.34
Price range $77.72 - $94.35
Increased shares by 170.7% (+9.27 Thousand shares) Q1 2019
Avg closing price $83.01
Price range $51.90 - $101.79
Sold 86.5% shares (-34.7 Thousand shares) Q4 2018
Avg closing price $61.05
Price range $48.76 - $76.44
Increased shares by 384.9% (+31.9 Thousand shares) Q3 2018
Avg closing price $70.47
Price range $35.64 - $92.06
Sold 65.9% shares (-16 Thousand shares) Q2 2018
Avg closing price $30.46
Price range $19.94 - $40.96
New holding (+24.3 Thousand shares) Q1 2018
Avg closing price $25.74
Price range $20.00 - $30.19

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!